Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Averyanov, A. Konoplyannikov, F. Zabozlaev, O. Danilevskaya, M. Konoplyannikov, O. Kuzovlev, N. Kulagina, I. Koroleva (Moscow, Obninsk, Russian Federation). Comparative effects of inhaled and intravenous mesenchymal stem cells in bleomycin-induced pulmonary fibrosis in rabbits. Eur Respir J 2013; 42: Suppl. 57, 226

Member's Comments

No comment yet.

Related content which might interest you: Effect of intratracheal administration of adipose-derived stromal cells on bleomycin-induced lung injury in a rat model Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Mesenchymal stem cells from adipose tissue reduce bleomycin-induced lung remodeling in late stage Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Abnormal proliferation and differentiation of c-kit+ lung stem cells in pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Different effects of mesenchymal stem cells on elastase-induced pulmonary emphysema and macrophages activity in rats Source: Annual Congress 2011 - Recent developments in COPD Year: 2011 Effect of nintedanib, pirfenidone, N-acetylcysteine and their combinations on cultured myofibroblast-type cells derived from patients with asbestosis and idiopathic pulmonary fibrosis Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 Role of HGF in the healthy and injured lung Source: International Congress 2015 – IIPs: orphan Year: 2015 FGF-9 overexpression prevents pleural fibrosis induced by intra-pleural adenovirus injection in mice Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 The effects of tobramycin on pulmonary fibroblast function Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Treprostinil administration attenuates bleomycin-induced lung fibrosis in mice Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Therapeutic benefits of exosomes derived from mesenchymal stromal cells in bleomycin-induced pulmonary fibrosis in aged mice. Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017 Effects of NecroX compounds on bleomycin-induced pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Uncoupling the pro-fibrotic effects of TGF-beta1 versus tissue hardening in lung fibroblasts Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 17(R)-resolvin D1 attenuates bleomycin-induced lung fibrosis in mice Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013 Effect of pirfenidone on TGF-beta-induced pro-fibrotic effects in primary human lung cells derived from patients with idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 2 Year: 2014 New approach to the treatment of bleomycin-induced lung fibrosis using pulmonary surfactant as pirfenidone carrier into the lung Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015 Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 LATE-BREAKING ABSTRACT: Anti-fibrotic effects of nintedanib and pirfenidone in 2D versus 3D lung cultures Source: International Congress 2016 – IPF pathogenesis Year: 2016 Pluripotent stem cells isolated from adult human lung tissue exhibit anti-fibrotic properties Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 PP238 – Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis Source: ERS Lung Science Conference 2021 Year: 2021 Effect of pirfenidone (PFD) on cytokine/chemokine release from alveolar macrophages (AMs) in interstitial lung diseases (ILD): Preliminary results Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013